Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
424 USD | -1.38% | +3.08% | +3.93% |
11:53am | Wolfe Research Adjusts Price Target on Vertex Pharmaceuticals to $520 From $497 | MT |
05-10 | Alpine Immune Sciences, Vertex Pharmaceuticals Deal Crosses Another Milestone | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.93% | 111B | |
+11.52% | 105B | |
-12.67% | 22.34B | |
-3.70% | 21.93B | |
-6.03% | 18.59B | |
-35.21% | 18.12B | |
-10.63% | 16.96B | |
+2.85% | 13.7B | |
+36.81% | 12.45B | |
+288.26% | 7.98B |
- Stock Market
- Equities
- VRTX Stock
- News Vertex Pharmaceuticals Incorporated
- Transcript : Vertex Pharmaceuticals Incorporated Presents at JPMorgan 34th Annual Healthcare Conference, Jan-11-2016 09